Skip to content

Effect of triamcinolone acetonide for parotid gland lavage on the salivary secretion of patients with Sjogren's syndrome

Effect of triamcinolone acetonide irrigation through parotid duct for parotid gland salivary secretion of patients with Sjogren's syndrome

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052314
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren syndrome

Interventions

Experimental Group:Perfusing parotid gland with triamcinolone acetonide injection through parotid duct
Control Group:The parotid gland was perfused with normal saline through parotid duct

Sponsors

Affiliated Stomatological Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria for Sj?gren's syndrome: 2012 ACR classification diagnostic criteria: (1) Serum anti-SSA and/or anti-SSB antibody positive, or rheumatoid factor RF positive with ANA >= 1:320; (2) OSS staining score >= 3 points; (3) Pathological biopsy of labial gland showed lymphocyte foci >=1/4 mm2 (at least 50 lymphocytes aggregated in 4 mm2 tissue); (4) The above 3 items meet 2 or more, and exclude the history of radiotherapy of neck, head and face, hepatitis C virus infection, AIDS, sarcoidosis, amyloidosis, graft-versus-host disease, IgG4-related diseases, namely Diagnosed as Sjogren's syndrome; 2. Patients who meet the above criteria, 20-80 years old, have symptoms of dry mouth, and the flow rate of saliva in a single parotid gland under acid stimulation is less than 1ml/5min.

Exclusion criteria

Exclusion criteria: Patients with overlap syndrome, systemic systemic diseases and salivary gland acute infectious diseases.

Design outcomes

Primary

MeasureTime frame
Acid stimulates salivary flow in parotid gland;Resting salivary flow in parotid gland;

Countries

China

Contacts

Public ContactDu Hongming

Affiliated Stomatological Hospital of Nanjing Medical University

dhm_010@sina.com+86 17721508525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026